Financial News
Xeris Pharmaceuticals Inc (NQ: XERS )
2.450
+0.080
(+3.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Xeris Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20231227139846/en/1980463/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
![](https://mms.businesswire.com/media/20231109523978/en/1940337/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/10/16/xers.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231016784672/en/1914394/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xeris Biopharma Holdings
August 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Xeris Pharmaceuticals's Earnings Outlook
March 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230927968185/en/1900518/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Announces Private Convertible Note Exchange Transactions
September 27, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230914198760/en/1890542/22/xeris_BIOPHARMA_TM_L.jpg)
Xeris to Participate in the 2023 Cantor Global Healthcare Conference
September 14, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/08/10/vicarious_surgical_-_logo.jpg?width=1200&height=800&fit=crop)
$8M Bet On Vicarious Surgical? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 10, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Xeris Biopharma Reports Second Quarter 2023 Financial Results
August 08, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Xeris Ships One Millionth Gvoke® Unit
July 31, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/06/29/bioxcel_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230621688257/en/1823683/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230509005324/en/1787045/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1563.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230502005125/en/1778742/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://mms.businesswire.com/media/20230418005445/en/1766301/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
![](https://mms.businesswire.com/media/20230330005239/en/1751597/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
![](https://mms.businesswire.com/media/20230329005369/en/1750285/5/Ricki_Fairley_Headshot.jpg)
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
March 29, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_150.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.